River Wealth Advisors’s GSK GSK Stock Holding History

River Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,592	Closed	-$76K	–	285
2018 Q4	$76K	Buy	1,592 +241	+18%	+$11.9K	0.03%	206
2018 Q3	$68K	Buy	1,351 +1	+0.1%	+$51	0.03%	243
2018 Q2	$68K	Buy	+1,350	New	+$68K	0.03%	242
2016 Q1	–	Sell	-4,171	Closed	-$210K	–	147
2015 Q4	$210K	Buy	+4,171	New	+$213K	0.13%	139

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

River Wealth Advisors's GSK Position: Q1 2019 in Review

River Wealth Advisors sold out of GSK (GSK) in Q1 2019, closing a stake of 1,592 shares — an estimated $76K sold.

River Wealth Advisors first reported a position in GSK in Q4 2015 and held it in 4 quarters. The position peaked at $210K in Q4 2015. 848 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

River Wealth Advisors reported no remaining GSK position as of Q1 2019 after selling out during the quarter.
River Wealth Advisors sold 1,592 GSK shares in Q1 2019, an estimated $76K.
River Wealth Advisors first reported a position in GSK in Q4 2015 and held it in 4 quarters.
River Wealth Advisors's GSK position peaked at $210K in Q4 2015.
848 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on River Wealth Advisors's 13F filing for Q1 2019, filed 7 May 2019.